project id: TCGA-UCEC; case submitter id: TCGA-AX-A3G1; source center: 23; state: released; a260 a280 ratio: 1.77; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.8; age at index: 84; days to birth: -31037; days to death: 624; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1925; year of death: 2010; age at diagnosis: 31037; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IC; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 765; initial weight: 40.0; oct embedded: false; preservation method: Unknown; sample id: 582513c5-474c-484e-ad98-811f0d4e07c6; sample submitter id: TCGA-AX-A3G1-01A; portion id: d1c66cba-e954-4c86-83d2-1c0332e8ace3; portion submitter id: TCGA-AX-A3G1-01A-11; slide id: 0b0d8597-b264-488f-8532-f005dd88efd5; slide submitter id: TCGA-AX-A3G1-01A-01-TS1; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 93.0; percent tumor nuclei: 92.0; section location: TOP;